MDR-1339
MDR-1339 (DWK-1339) is an orally active and blood-brain-barrier-permeable Aβ-aggregation inhibitor, used in the research of Alzheimer's disease.
Product Specifications
CAS Number
[1018946-38-7]
Product Name Alternative
DWK-1339
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Amyloid-β
Type
Reference compound
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/DWK-1339.html
Concentration
10mM
Purity
99.95
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
COCCCC1=CC=C(OC(C2=CC=C(OC)C(OC)=C2)=C3)C3=C1
Molecular Formula
C20H22O4
Molecular Weight
326.39
Precautions
H315, H319, H335
References & Citations
[1]Ha HJ, et al. Discovery of an Orally Bioavailable Benzofuran Analogue That Serves as a β-Amyloid Aggregation Inhibitor for the Potential Treatment of Alzheimer's Disease. J Med Chem. 2018 Jan 11;61 (1) :396-402.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
033846-ML405 100 µL
CHIC2, CT (CHIC2, BTL, Cysteine-rich hydrophobic domain 2 protein, BrX-like translocated in leukemia) (MaxLight 405) discontinued
Ask
View Details MBS6353104-01 0.2 mL
SYTL3, NT (SYTL3, SLP3, Synaptotagmin-like protein 3, Exophilin-6) (PE)
Ask
View Details